[News] WHO prequalifies novel polio vaccine | ClinicLens

On Feb 10, 2026, WHO prequalified a novel oral polio vaccine type 2 (nOPV2; Biological E [BioE], India). The product was developed following a technology transfer from PT Bio Farma (Indonesia). Designed to address outbreaks of circulating vaccine-derived poliovirus type 2 (cVDPV2

Medical Literature · Updated 2026-08-03

← Back to articles

This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.